DEADLINE ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health - Marketscreener.com
| 301267 Stock | 20.44 0.26 1.29% |
About 53% of Huaxia Eye's investors are presently thinking to get in. The analysis of overall sentiment of trading Huaxia Eye Hospital stock suggests that some investors are interested at this time. The current market sentiment, together with Huaxia Eye's historical and current headlines, can help investors time the market. In addition, many technical investors use Huaxia Eye Hospital stock news signals to limit their universe of possible portfolio assets.
Huaxia |
DEADLINE ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health Marketscreener.com
Read at news.google.com
 |
Huaxia Eye Fundamental Analysis
We analyze Huaxia Eye's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Huaxia Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Huaxia Eye based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Huaxia Eye is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Huaxia Eye Hospital Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Huaxia Eye stock to make a market-neutral strategy. Peer analysis of Huaxia Eye could also be used in its relative valuation, which is a method of valuing Huaxia Eye by comparing valuation metrics with similar companies.
Peers
Huaxia Eye Related Equities
| 601928 | Jiangsu Phoenix | 2.45 | ||||
| 601921 | Zhejiang Publishing | 1.35 | ||||
| 300848 | Miracll Chemicals | 0.12 | ||||
| 002659 | Beijing Kaiwen | 1.27 | ||||
| 603255 | Liaoning Dingjide | 1.99 | ||||
| 000995 | Gansu Huangtai | 2.84 | ||||
| 002188 | Bus Online | 2.95 |
Complementary Tools for Huaxia Stock analysis
When running Huaxia Eye's price analysis, check to measure Huaxia Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Huaxia Eye is operating at the current time. Most of Huaxia Eye's value examination focuses on studying past and present price action to predict the probability of Huaxia Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Huaxia Eye's price. Additionally, you may evaluate how the addition of Huaxia Eye to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |